Skip to main content
. 2023 Jun 29;13(6):e065369. doi: 10.1136/bmjopen-2022-065369

Table 2.

Inclusion and exclusion criteria for single dose rifampicin

Inclusion criteria Exclusion criteria
1. Enrolled in the screening intervention 1. History of serious liver or kidney disease.
2. Not eligible for any other rifamycin-based treatment 2. Known pregnancy (SDR can be given after delivery).
3. Aged ≥2 years 3. Known allergy or severe adverse effects experienced with rifampicin use.
4. Informed consent. For children (<18 years) consent will be obtained from the parent or guardian, and children (≥10 years) will also provide assent. 4. Refuses participation.

Inclusion criteria are shown for single dose rifampicin. Other treatment regimens are determined by indications and contraindications relevant to those regimens.

SDR, single-dose rifampicin.